Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00034112
Status:
COMPLETED
Last Update Posted:
2006-08-18
First Post:
2002-04-22
Brief Title:
Efficacy of Osteopathic Manipulation in Chronic Obstructive Pulmonary Disease
Sponsor:
National Center for Complementary and Integrative Health NCCIH
Organization:
National Center for Complementary and Integrative Health NCCIH
Study Overview
Official Title:
Efficacy of Osteopathic Manipulation in Chronic Obstructive Pulmonary Disease
Status:
COMPLETED
Status Verified Date:
2006-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if osteopathic manipulative treatment OMT is effective for persons with emphysema as a component of their chronic obstructive pulmonary disease
Detailed Description:
OMT sessions are designed to improve chest wall compliance and diaphragmatic function which produce an immediate positive change in pulmonary function parameters and chest wall mobility This research project will be a significant step in expanding the understanding of the role of OMT in the treatment of chronic lung disease It is expected to yield evidence that OMT is an important adjunctive modality that improves pulmonary function increases exercise tolerance relieves dyspnea and improves quality of life in those with COPD and that would have widespread clinical application plus significant economic benefits
Participants in this study will be randomly assigned to receive either OMT or sham treatments once a week for 13 weeks Outcome measures will be obtained at baseline immediately following the first treatment at 4 8 and 12 weeks after initiation of treatment and 4 weeks after termination of the treatment Outcome variables include pulmonary function tests quality-of-life questionnaires including emotional functioning fatigue and dyspnea and measurements of exercise tolerance and chest wall mobility
Participants in this study will be randomly assigned to receive either OMT or sham treatments once a week for 13 weeks Outcome measures will be obtained at baseline immediately following the first treatment at 4 8 and 12 weeks after initiation of treatment and 4 weeks after termination of the treatment Outcome variables include pulmonary function tests quality-of-life questionnaires including emotional functioning fatigue and dyspnea and measurements of exercise tolerance and chest wall mobility
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None